Ymmunobio AG (YB), a Swiss-based global biotech company dedicated to the development of new cancer therapeutics, is proud to announce that its two-antibody drug conjugate (ADC) assets, YB-800ADC1 and ...

Simone and Malcolm Collins started out with two elite degrees, a startup and a progressive vision for the future. Now, ...

Baidu, Inc. , a leading AI company with a strong internet foundation, today introduced a new suite of AI innovations at its annual developer conference Baidu Create 2025. At the event, Baidu ...

Free parking is available for all attendees as indicated on the map below. Conference guests can park in the ... excel in design and manufacturing to ensure seamless scale-up from concept to ...

Today, as we mark World Malaria Day, we're highlighting innovative approaches that can drive progress toward eliminating this ...

Many patent applicants currently face difficulty in obtaining antibody claims because of written description and enablement ...

Discover how early functional screening at the single-cell level transforms therapeutic development of your antibodies.

Get Instant Summarized Text (Gist) An AI-driven platform has been used to optimize an antibody, 3152-1142, to neutralize a wide range of SARS-CoV-2 variants, enhancing its potency against ...

An antibody (teal) bound to its target, the HIV protein Env (white and gray), also attaches to an immune cell via a receptor (red) on the immune cell’s surface. This interaction can activate the ...

It’s based on the same VHH antibody concept from camelids — from our coverage earlier this week: Researchers from the Kitasato University in Japan worked with Kao and biotech startup Epsilon ...